Clinical Trial Update: Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fludarabine and intermediate-dose total body irradiation followed by post-transplant cyclophosphamide in patients undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Allogeneic Stem Cell Transplant Recipient | Phase 2 | Status: RECRUITING